$0.420
-0.213 (-50.71%)At close
ATXI Comparative Benchmarking
In the context of the broader market, ATXI competes directly with industry leaders such as WINT and SHPH. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, ATXI's gross margin of N/A stands against WINT's N/A and SHPH's N/A. Such benchmarking helps identify whether Avenue Therapeutics Inc is trading at a premium or discount relative to its financial performance.
Financials
FY2024Q3
YoY:
+52.61%
-3.16M
Operating Profit
FY2024Q3
YoY:
-701.75%
-3.09M
Net Income after Tax
FY2024Q3
YoY:
-139.92%
-1.92
EPS - Diluted
FY2024Q3
YoY:
+224.97%
-2.89M
Free Cash Flow
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.